Ameriprise Financial Inc Aclaris Therapeutics, Inc. Transaction History

Ameriprise Financial Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$0.92 - $1.44 $1,643 - $2,571	-1,786 Reduced 2.76%	62,974 $78,000
Q4 2023 Feb 14, 2024	SELL	$0.64 - $6.49 $8,163 - $82,779	-12,755 Reduced 16.45%	64,760 $67,000
Q3 2023 Nov 14, 2023	BUY	$6.56 - $10.95 $8,383 - $13,994	1,278 Added 1.68%	77,515 $530,000
Q2 2023 Aug 14, 2023	BUY	$7.89 - $10.64 $34,495 - $46,518	4,372 Added 6.08%	76,237 $790,000
Q1 2023 May 15, 2023	SELL	$7.07 - $17.95 $3,994 - $10,141	-565 Reduced 0.78%	71,865 $581,000
Q4 2022 Feb 14, 2023	SELL	$14.33 - $18.37 $12,108 - $15,522	-845 Reduced 1.15%	72,430 $1.14 Million
Q3 2022 Nov 14, 2022	SELL	$13.07 - $18.22 $26,754 - $37,296	-2,047 Reduced 2.72%	73,275 $1.15 Million
Q2 2022 Aug 15, 2022	SELL	$10.16 - $17.08 $7,416 - $12,468	-730 Reduced 0.96%	75,322 $1.05 Million
Q1 2022 May 16, 2022	BUY	$9.74 - $17.92 $17,473 - $32,148	1,794 Added 2.42%	76,052 $1.31 Million
Q4 2021 Feb 14, 2022	BUY	$12.27 - $18.49 $911,145 - $1.37 Million	74,258 New	74,258 $1.08 Million

50.7M

30.6K

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $253M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Ameriprise Financial Inc with notifications on news.